JP2021511324A5 - - Google Patents

Info

Publication number
JP2021511324A5
JP2021511324A5 JP2020539784A JP2020539784A JP2021511324A5 JP 2021511324 A5 JP2021511324 A5 JP 2021511324A5 JP 2020539784 A JP2020539784 A JP 2020539784A JP 2020539784 A JP2020539784 A JP 2020539784A JP 2021511324 A5 JP2021511324 A5 JP 2021511324A5
Authority
JP
Japan
Prior art keywords
methoxy
dihydro
pyrrolidine
fluoro
trifluoromethylbenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020539784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511324A (ja
JP7281469B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/051230 external-priority patent/WO2019141803A1/en
Publication of JP2021511324A publication Critical patent/JP2021511324A/ja
Publication of JP2021511324A5 publication Critical patent/JP2021511324A5/ja
Application granted granted Critical
Publication of JP7281469B2 publication Critical patent/JP7281469B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020539784A 2018-01-19 2019-01-18 C5a受容体調節剤 Active JP7281469B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2018051278 2018-01-19
EPPCT/EP2018/051278 2018-01-19
PCT/EP2019/051230 WO2019141803A1 (en) 2018-01-19 2019-01-18 C5a receptor modulators

Publications (3)

Publication Number Publication Date
JP2021511324A JP2021511324A (ja) 2021-05-06
JP2021511324A5 true JP2021511324A5 (cg-RX-API-DMAC7.html) 2022-01-21
JP7281469B2 JP7281469B2 (ja) 2023-05-25

Family

ID=65023914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020539784A Active JP7281469B2 (ja) 2018-01-19 2019-01-18 C5a受容体調節剤

Country Status (6)

Country Link
US (1) US11739070B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740476A1 (cg-RX-API-DMAC7.html)
JP (1) JP7281469B2 (cg-RX-API-DMAC7.html)
CN (1) CN111615513A (cg-RX-API-DMAC7.html)
CA (1) CA3087886A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019141803A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA124694C2 (uk) 2018-01-10 2021-10-27 Ідорсія Фармасьютікалз Лтд 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ
WO2019141803A1 (en) 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators
US11685729B2 (en) 2018-01-19 2023-06-27 Idorsia Pharmaceuticals Ltd. C5a receptor modulators
DK3808747T3 (da) * 2018-09-13 2025-02-03 Kissei Pharmaceutical Imidazopyridinon-forbindelse
JP7654426B2 (ja) * 2020-03-12 2025-04-01 キッセイ薬品工業株式会社 イミダゾピリジノン化合物の製造方法
KR20240021883A (ko) 2021-06-16 2024-02-19 셀진 코포레이션 신경변성 질환의 치료를 위한 카르복실산 기를 포함하는 아제티디닐 화합물
WO2026013291A1 (en) * 2024-07-11 2026-01-15 University Of Dundee Inhibitors of rna methyltransferase

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125286A (en) * 1975-02-14 1976-11-01 Yoshitomi Pharmaceut Ind Ltd A process for preparing novel 3- substituted n-benzylpyrrolidine deriv atives
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
PL342046A1 (en) 1998-01-19 2001-05-21 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor
KR100607634B1 (ko) 1998-10-16 2006-08-02 다이닛본 스미토모 세이야꾸 가부시끼가이샤 퀴나졸리논 유도체
PL347432A1 (en) 1998-10-23 2002-04-08 Hoffmann La Roche Bicyclic nitrogen heterocycles
TR200200161T2 (tr) 1999-07-21 2002-05-21 Fujisawa Pharmaceutical Co. Ltd. Benzimidazol türevleri ve onların fosfodiesteraz olarak kullanımı.
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2003037890A2 (en) 2001-11-01 2003-05-08 Icagen, Inc. Piperidines
CN100360130C (zh) 2002-04-18 2008-01-09 先灵公司 用作组胺h3拮抗剂的1-(4-哌啶基)苯并咪唑酮
JP2007515458A (ja) 2003-12-23 2007-06-14 テイボテク・フアーマシユーチカルズ・リミテツド Hivプロテアーゼ阻害剤の自己ミクロ乳化性薬剤送達システム
ATE518840T1 (de) 2007-05-22 2011-08-15 Boehringer Ingelheim Int Benzimidazolonchymasehemmer
US8940725B2 (en) 2010-05-31 2015-01-27 Ono Pharmaceutical Co., Ltd. Purinone derivative
US20120143725A1 (en) 2010-12-02 2012-06-07 Vinimaya Inc. Methods and systems for influencing search and shopping decisions in electronic procurement
GB201106814D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compounds
MX2016002544A (es) 2013-09-04 2016-06-17 Squibb Bristol Myers Co Compuestos utiles como inmunomoduladores.
RS57508B1 (sr) 2013-09-06 2018-10-31 Aurigene Discovery Tech Ltd 1,2,4-derivati oksadiazola kao imunomodulatori
WO2015044900A1 (en) 2013-09-27 2015-04-02 Aurigene Discovery Technologies Limited Therapeutic immunomodulating compounds
UA124694C2 (uk) 2018-01-10 2021-10-27 Ідорсія Фармасьютікалз Лтд 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ
US11685729B2 (en) 2018-01-19 2023-06-27 Idorsia Pharmaceuticals Ltd. C5a receptor modulators
WO2019141803A1 (en) 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators

Similar Documents

Publication Publication Date Title
AU2013329552B2 (en) 5-phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors
JP2024513881A5 (cg-RX-API-DMAC7.html)
JP2022189853A5 (cg-RX-API-DMAC7.html)
JP2018520105A5 (cg-RX-API-DMAC7.html)
EP2655340B1 (en) Bi-heteroaryl compounds as vps34 inhibitors
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2023506642A5 (cg-RX-API-DMAC7.html)
US20210128723A1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
IL299180A (en) 2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
US7696201B2 (en) Modulators of muscarinic receptors
JP2016519096A5 (cg-RX-API-DMAC7.html)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
CA2984259A1 (en) Combinations of inhibitors of irak4 with inhibitors of btk
JP2019509319A5 (cg-RX-API-DMAC7.html)
JP2024521618A5 (cg-RX-API-DMAC7.html)
JP2013531070A5 (cg-RX-API-DMAC7.html)
JP2013526536A5 (cg-RX-API-DMAC7.html)
JP2018530591A5 (cg-RX-API-DMAC7.html)
JP2016514718A5 (cg-RX-API-DMAC7.html)
JP2014531465A5 (cg-RX-API-DMAC7.html)
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
JP2022551422A5 (cg-RX-API-DMAC7.html)
US11660301B2 (en) Combination of ATR kinase inhibitors with PARP inhibitors
JP2007509106A5 (cg-RX-API-DMAC7.html)
JP2017519729A5 (cg-RX-API-DMAC7.html)